![TRACON Pharmaceuticals Inc](/common/images/company/N_TCON.png)
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to de... TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, TJ4309, Bispecific Antibodies. Show more
SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (OTCQB: TCON) today announced that the Company has terminated its employees and will wind down its operations. This decision...
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0.15 | 11.71875 | 1.28 | 1.77 | 0.66 | 226990 | 1.20869612 | CS |
26 | -1.83 | -56.1349693252 | 3.26 | 14.746 | 0.66 | 2346696 | 7.20032187 | CS |
52 | -3.57 | -71.4 | 5 | 14.746 | 0.66 | 2697952 | 5.1571089 | CS |
156 | -78.57 | -98.2125 | 80 | 89.8 | 0.66 | 921440 | 8.85812752 | CS |
260 | -8.598 | -85.739928201 | 10.028 | 244 | 0.66 | 769498 | 33.53582183 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.